Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05307055 · ClinicalTrials.gov registry record · NA

Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation

A NA study of Parkinson Disease, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05307055 is a NA study of Parkinson Disease that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 40 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05307055, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine whether direct brain stimulation of specific regions and ranges improves cognition in people with Parkinsons Disease (PD) who already have a deep brain stimulator implanted. Research activities consist of 32 subjects undergoing stimulation changes to their device and being administered neurocognitive tests to evaluate the changes. An fMRI scan will also be done at baseline and at weeks 15 and 27. All subjects will undergo the stimulation changes in a randomized double blind crossover study. Evaluation of stimulation changes will be assessed through analysis of neurocognitive data.

Conditions Studied

Interventions

  • DEVICE STN DBS - Theta Burst
  • DEVICE STN DBS - Gamma

Study Locations (1)

California

  • University of Southern California Keck School of Medicine - Los Angeles

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-01-11
Est. Completion 2029-08-31
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT05307055

The ClinicalTrials.gov registry entry for NCT05307055 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which STN DBS - Theta Burst is the first listed.

NCT05307055 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05307055 about?

NCT05307055 is a clinical study titled "Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation". This study aims to determine whether direct brain stimulation of specific regions and ranges improves cognition in people with Parkinsons Disease (PD) who already have a deep brain stimulator implanted. Research activities consist of 32 subjects undergoing stimulation changes to their device and bei...

What is the current status of trial NCT05307055?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-01-11. Estimated completion is 2029-08-31.

What conditions does trial NCT05307055 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05307055?

The interventions under investigation include: STN DBS - Theta Burst (DEVICE), STN DBS - Gamma (DEVICE).

Who is sponsoring clinical trial NCT05307055?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05307055 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.